HOME >> BIOLOGY >> NEWS
ART laws put patients at risk and should be changed, warns head of Germany's IVF registry

Madrid, Spain: Germany's restrictive legislation on embryo protection is putting women and babies at risk and should be modified, the chairman of the German IVF registry will tell a meeting of international fertility experts.

Professor Ricardo Felberbaum will warn participants at the European Society of Human Reproduction and Embryology annual conference that other countries in Europe should take heed of the German experience when formulating their own legislation on embryo selection, storage and implantation.

Since January 1991, under German law a maximum of three embryos can be transferred to a woman's uterus, but only as many female eggs (oocytes) can be fertilized as planned to be transferred, and then they all have to be transferred in one go, regardless of quality, because embryo selection and storage by freezing is forbidden. Only freezing of oocytes in the pronuclear stage is allowed, which means that selection has to be performed at that stage of development and not later.

These laws were thought to guarantee a low incidence of multiple births, but Prof Felberbaum said that, in fact, this goal was not achieved.

He studied data from 108 IVF centres on 75,086 treatment cycles in 2001. Out of 9,648 children born after ART 62% (5,969) were singletons, 34% (3,326) were twins and 3.6% (353) were triplets. There was a strong correlation between the number of embryos transferred and the incidence of multiple pregnancies. In women under 35, 24% of pregnancies were twins after the transfer of two embryos, and when three embryos were transferred 28% were twins and just over 5% were triplets.

The quality of the embryos transferred dramatically affected pregnancy rates: when two, high-quality embryos were transferred there was an overall pregnancy rate of 32%, but when two, low-quality embryos were transferred the overall pregnancy rate dropped to just 13%.

Prof. Felberbaum told a news briefing today (Monday 30 June): "Ger
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-137-656-3090
European Society for Human Reproduction and Embryology
30-Jun-2003


Page: 1 2 3

Related biology news :

1. Trial shows which brain cancer patients benefit from temozolomide
2. Study of flu patients reveals virus outsmarting key drug
3. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
4. Activated signaling pathway may predict lung cancer patients response to gefitinib
5. Targeted therapy for lung cancer patients shows promise in extending lives
6. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
7. Study finds that only half of a commonly used cancer drug is activated in cancer patients
8. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere
9. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
10. Lung cancer patients in Japan, United States react differently to the same chemotherapy regimen
11. Gene expression ratio identifies risk of recurrence in breast cancer patients receiving tamoxifen

Post Your Comments:
(Date:5/21/2013)... , May 21, 2013 Royal Philips Electronics ... the world,s first portable ultrasound with Philips, industry leading ... capability. The CX50 xMATRIX with available Live 3D TEE ... at the EuroPCR, official meeting for the ... Since its launch in 2012, Philips CX50 ...
(Date:5/20/2013)... about the effect of physical education (PE) on child ... that increasing the amount of time that elementary schoolchildren ... , The study represents some of the first evidence ... and is forthcoming in the Journal of Health ... study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , ...
(Date:5/20/2013)... (May 20, 2013) - A novel vaccine ... the groundbreaking research that will be unveiled at the ... (NBC). The meeting takes place Monday, May 20 - ... and Marina. , "The main goal of a ... against a pathogen that causes the disease", explained Dr. ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Gym class reduces probability of obesity, study finds for first time 2Germ-fighting vaccine system makes great strides in delivery 2
(Date:5/21/2013)... 2013 Revolutionary Science, the manufacturer of ... announced today that they have expanded their colony counter ... IncuCount, IntelliCount, InCount and ImpressCount. These affordable colony ... useful in food microbiology and pharmaceutical manufacturing. , The ... A bright white enclosure with jet black accents ...
(Date:5/21/2013)... May 21, 2013 SoundConnect is pleased ... Microsoft Lync, for customers in Canada. Lync is ... and will allow businesses and organizations to collaborate and ... SoundConnect released Lync in the United States. With the ... the product release in Canada, SoundConnect now offers a ...
(Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
(Date:5/20/2013)...  Dr. Gerald Zon , noted ... launched a new blog in conjunction with TriLink BioTechnologies. ... focuses on what,s trending in the field of nucleic ... discussions of research presented at conferences and meetings, reviews ... Zon (PhD Princeton University 1971) developed automated synthesis of ...
Breaking Biology Technology:Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2
Cached News: